Special Consideration of Sedative-Hypnotic and Antianxiety Agents in Rehabilitation

Problem/lnfluence of Medication. During his daily rehabilitation regimen, the therapists noted that R.S. s performance and level of attentiveness were markedly poor during the morning sessions. He was excessively lethargic and drowsy, and his speech was slurred. These symptoms were [Pg.74]

Allgulander C, Bandelow B, Hollander E, et al. WCA recommendations for the long-term treatment of generalized anxiety disorder. CNS Spectr. 2003 8(suppl 1) 53-61. [Pg.74]

Apter JT, Allen LA. Buspirone future directions. J Clin Psychopharmacol. 1999 19 86—93. [Pg.74]

AtackJR. Anxioselective compounds acting at the GABA (A) receptor benzodiazepine binding site. Curr Drug Targets CNS Neurol Disord. 2003 2 213-232. [Pg.74]

Bandelow B, Zohar J, Hollander E, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders. World J Biol Psychiatry. 2002 3 171-199. [Pg.74]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...